OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Virus infection induced pulmonary fibrosis
Wei Huang, Xiao Xiao Tang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Wei Huang, Xiao Xiao Tang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Showing 1-25 of 108 citing articles:
Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis
Jun-Hao Wen, Dong-Yi Li, Shan Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 100
Jun-Hao Wen, Dong-Yi Li, Shan Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 100
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 95
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 95
Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis
Weiming Zhao, Lan Wang, Yaxuan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8749-8749
Open Access | Times Cited: 27
Weiming Zhao, Lan Wang, Yaxuan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8749-8749
Open Access | Times Cited: 27
Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis
Dongjun Li, Ang Zhao, Jiafei Zhu, et al.
Small (2023) Vol. 19, Iss. 30
Closed Access | Times Cited: 26
Dongjun Li, Ang Zhao, Jiafei Zhu, et al.
Small (2023) Vol. 19, Iss. 30
Closed Access | Times Cited: 26
Neutralizing antibodies to block viral entry and for identification of entry inhibitors
Ee-Hong Tam, Peng Yu, Megan Xin Yan Cheah, et al.
Antiviral Research (2024) Vol. 224, pp. 105834-105834
Closed Access | Times Cited: 8
Ee-Hong Tam, Peng Yu, Megan Xin Yan Cheah, et al.
Antiviral Research (2024) Vol. 224, pp. 105834-105834
Closed Access | Times Cited: 8
hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1
Yanyang Wang, Chan Liu, Nuoxin Wang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Yanyang Wang, Chan Liu, Nuoxin Wang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis
Anamika Gupta, Manju Nidagodu Jayakumar, Mohamed A. Saleh, et al.
Life Sciences (2022) Vol. 304, pp. 120703-120703
Open Access | Times Cited: 36
Anamika Gupta, Manju Nidagodu Jayakumar, Mohamed A. Saleh, et al.
Life Sciences (2022) Vol. 304, pp. 120703-120703
Open Access | Times Cited: 36
Lung fibrosis: Post-COVID-19 complications and evidences
Rishabh Hirawat, Namrata G. Jain, Mohd Aslam Saifi, et al.
International Immunopharmacology (2022) Vol. 116, pp. 109418-109418
Open Access | Times Cited: 32
Rishabh Hirawat, Namrata G. Jain, Mohd Aslam Saifi, et al.
International Immunopharmacology (2022) Vol. 116, pp. 109418-109418
Open Access | Times Cited: 32
Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization
Qixin Wang, Isaac K. Sundar, Joseph H. Lucas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Qixin Wang, Isaac K. Sundar, Joseph H. Lucas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Qimai Feiluoping decoction inhibits mitochondrial complex I-mediated oxidative stress to ameliorate bleomycin-induced pulmonary fibrosis
Lu Ding, Yingying Yang, Zeyu Wang, et al.
Phytomedicine (2023) Vol. 112, pp. 154707-154707
Open Access | Times Cited: 16
Lu Ding, Yingying Yang, Zeyu Wang, et al.
Phytomedicine (2023) Vol. 112, pp. 154707-154707
Open Access | Times Cited: 16
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers
Aurelio Perez-Favila, Idalia Garza‐Veloz, Lucia del Socorro Hernandez-Marquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1562-1562
Open Access | Times Cited: 7
Aurelio Perez-Favila, Idalia Garza‐Veloz, Lucia del Socorro Hernandez-Marquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1562-1562
Open Access | Times Cited: 7
Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges
Yixiang Hu, Ying Huang, Lijuan Zong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Yixiang Hu, Ying Huang, Lijuan Zong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis
Bo Ran, Xiaohong Ren, Xueyuan Lin, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 811-820
Closed Access | Times Cited: 5
Bo Ran, Xiaohong Ren, Xueyuan Lin, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 811-820
Closed Access | Times Cited: 5
Myofibroblasts reduce angiogenesis and vasculogenesis in a vascularized microphysiological model of lung fibrosis
Elena Cambria, Adriana Blazeski, Eunkyung Ko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Elena Cambria, Adriana Blazeski, Eunkyung Ko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting endothelial cells: A novel strategy for pulmonary fibrosis treatment
Xin Zhang, Yuxia Sha, Yu‐Wei Wu, et al.
European Journal of Pharmacology (2025), pp. 177472-177472
Closed Access
Xin Zhang, Yuxia Sha, Yu‐Wei Wu, et al.
European Journal of Pharmacology (2025), pp. 177472-177472
Closed Access
Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort Study
Alba Mulet, Julia Tarrasó, Enrique Rodríguez–Borja, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 3, pp. 321-327
Open Access | Times Cited: 12
Alba Mulet, Julia Tarrasó, Enrique Rodríguez–Borja, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 3, pp. 321-327
Open Access | Times Cited: 12
O‐GlcNAcylation Regulates Centrosome Behavior and Cell Polarity to Reduce Pulmonary Fibrosis and Maintain the Epithelial Phenotype
Yu Fan, Song Yang, Hua Ni, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 11
Yu Fan, Song Yang, Hua Ni, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 11
Neutrophil Activity and Extracellular Matrix Degradation: Drivers of Lung Tissue Destruction in Fatal COVID-19 Cases and Implications for Long COVID
Teluguakula Narasaraju, Indira Neeli, Sheila Criswell, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 236-236
Open Access | Times Cited: 4
Teluguakula Narasaraju, Indira Neeli, Sheila Criswell, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 236-236
Open Access | Times Cited: 4
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung
Joel S. Greenberger, Wen‐Chi Hou, Donna Shields, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1546-1556
Open Access | Times Cited: 4
Joel S. Greenberger, Wen‐Chi Hou, Donna Shields, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1546-1556
Open Access | Times Cited: 4
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Role of CCL2/CCR2 Axis in Pulmonary Fibrosis Induced by Respiratory Viruses
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
“Idiopathic” adhesive capsulitis is caused by reactivation of latent neurotrophic virus involving peripheral nerves around the shoulder capsule: A hypothesis
Wei Xia, R Risco Cortés, Kuen Chin, et al.
Medical Hypotheses (2025), pp. 111604-111604
Closed Access
Wei Xia, R Risco Cortés, Kuen Chin, et al.
Medical Hypotheses (2025), pp. 111604-111604
Closed Access
Clinical application and molecular mechanisms of chinese medicine formulas in fibrotic diseases: A narrative review
Yanan Xia, Qiuhuan Yuan, Liu X, et al.
(2025) Vol. 1, Iss. 2, pp. 100024-100024
Open Access
Yanan Xia, Qiuhuan Yuan, Liu X, et al.
(2025) Vol. 1, Iss. 2, pp. 100024-100024
Open Access
Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway
Wei-Chung Chiou, Guan‐Jhong Huang, Tein‐Yao Chang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114481-114481
Open Access | Times Cited: 10
Wei-Chung Chiou, Guan‐Jhong Huang, Tein‐Yao Chang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114481-114481
Open Access | Times Cited: 10
Immune-mediated lung diseases: A narrative review
Jaleel Jerry G. Sweis, Nabil William G Sweis, Fatima Alnaimat, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Jaleel Jerry G. Sweis, Nabil William G Sweis, Fatima Alnaimat, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
